MedTrace Logo

A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children

NCT05142813 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2022-03-29

No results posted yet for this study

Summary

A case-control cohort study to develop and validate the performance of a whole blood gene expression test to distinguish sepsis infection from uninfected systemic inflammatory response syndrome cases in symptomatic adults and children without comorbidities.

Conditions

Interventions

DIAGNOSTIC_TEST

Diagnostic Test: Blood specimen collection

Diagnostic Test: Blood specimen collection Study samples must be collected within before treatment with antibiotics or antivirals.

Sponsors & Collaborators

  • The Second Afliated Hospital of Southern University of Science and Technology

    collaborator UNKNOWN

  • mProbe Inc.

    lead INDUSTRY

Principal Investigators

  • Jia Huang · The Second Afliated Hospital of Southern University of Science and Technology

Eligibility

Min Age
90 Days
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2023-06-30
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05142813 on ClinicalTrials.gov